Results 251 to 260 of about 83,570 (294)
Some of the next articles are maybe not open access.
Treating carbapenem-resistant Acinetobacter baumannii infections
The Lancet Infectious Diseases, 2023Not required for the type of ...
Giannella M., Viale P.
openaire +3 more sources
Carbapenem‐resistant Enterobacteriaceae: biology, epidemiology, and management [PDF]
Annals of the New York Academy of Sciences, 2014 Introduced in the 1980s, carbapenem antibiotics have served as the last line of defense against multidrug‐resistant Gram‐negative organisms. Over the last decade, carbapenem‐resistant Enterobacteriaceae (CRE) have emerged as a significant public health threat.
Amos Adler, Yehuda Carmeli
exaly +4 more sources
Options for treating carbapenem-resistant Enterobacteriaceae
Current Opinion in Infectious Diseases, 2014To address the therapeutic management of carbapenem-resistant Enterobacteriaceae on the basis of literature of the last 12 months.Retrospective and prospective (nonrandomized noncontrolled) studies provide data regarding the management of infections due to carbapenem-resistant Enterobacteriaceae.
Petros I, Rafailidis, Matthew E, Falagas
openaire +2 more sources